Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-08-31
1988-05-10
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514445, 514448, 514471, 549 62, 549 64, 549 65, 549 71, 549 74, 549475, 549476, 549478, 549484, 549485, 549486, 549491, A61K 3138, A61K 3134, C07D33312, C07D30702
Patent
active
047436174
ABSTRACT:
This invention relates to novel heterocyclyl-2-propyn-1-amines which are useful as dopamine beta hydroxylase inhibitors in the treatment of hypertension.
REFERENCES:
patent: 3211741 (1965-10-01), Martin et al.
patent: 4128561 (1978-12-01), Braye
Padgett, S. R., Wimalasena, K., Herman, H. H. Sirimanne, S. R., and May, S. W., Biochemistry, 24, 5826-5839, 1985.
Colombo, G. and Villafranca, J., J. Biol. Chem. 259(24), 15017-15020, 1984.
Bargar Thomas M.
Creemer Lawrence C.
McCarthy James R.
Merrell Dow Pharmaceuticals Inc.
Siegel Alan
LandOfFree
Heterocyclyl-2-propyn-1-amines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclyl-2-propyn-1-amines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclyl-2-propyn-1-amines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1321310